Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is seeing a 58-year-old man with
newly diagnosed hypertension. The patient asks whether the
medication that "worked well" for his brother would also be the best
choice for him. Which response best reflects evidence-based
prescribing?
A. Prescribe the same medication because first-degree relatives usually
respond similarly to drug therapy.
B. Recommend delaying treatment until pharmacogenomic testing is
completed for all antihypertensive medications.
C. Select therapy after considering the patient's diagnosis,
comorbidities, current medications, kidney function, adverse-effect
risk, cost, and treatment goals.
D. Allow the patient to choose the medication based primarily on
internet reviews because adherence improves when patients select
their own therapy.
Correct Answer: C
Rationale:
Evidence-based prescribing integrates the best available evidence with
individual patient characteristics, clinician expertise, and patient
preferences. Medication selection should account for comorbidities,
concomitant medications, renal/hepatic function, adverse-effect
profiles, affordability, and therapeutic goals. Family response alone (A)
is insufficient to guide prescribing. Pharmacogenomic testing (B) has
specific indications but is not routinely required before initiating
antihypertensive therapy. Patient preferences are important, but
medication selection should not rely primarily on anecdotal reviews (D).
,Question 2
A newly licensed APRN is preparing to prescribe medications
independently. Before initiating pharmacotherapy, which action best
promotes patient safety?
A. Prescribe the newest medication available because it is likely to be
more effective.
B. Perform medication reconciliation, review allergies, assess for drug
interactions, and confirm the indication for therapy.
C. Avoid discussing potential adverse effects to prevent reducing
medication adherence.
D. Use medication samples whenever possible instead of reviewing
insurance coverage.
Correct Answer: B
Rationale:
Medication reconciliation is a fundamental patient safety practice.
Reviewing current medications, allergies, potential interactions,
contraindications, and the clinical indication helps prevent prescribing
errors and adverse drug events. Newer medications (A) are not
inherently superior and may have less post-marketing safety data.
Counseling regarding adverse effects (C) improves informed decision-
making and appropriate monitoring. Insurance coverage and cost
should be considered, but samples (D) should not replace
comprehensive prescribing evaluation.
Question 3
, A 76-year-old woman with chronic kidney disease, osteoarthritis,
hypertension, and type 2 diabetes takes eight prescription medications
and several over-the-counter supplements. Which prescribing approach
is most appropriate?
A. Add the necessary medication without reviewing the existing
regimen to avoid delaying treatment.
B. Focus only on the medication being prescribed because other
clinicians manage the remaining therapies.
C. Review all prescription medications, over-the-counter products,
herbal supplements, renal function, and potential drug interactions
before prescribing.
D. Discontinue all over-the-counter medications because they are not
evidence-based.
Correct Answer: C
Rationale:
Older adults with polypharmacy have an increased risk of adverse drug
events, drug interactions, and medication-related complications. A
comprehensive medication review, including prescription medications,
nonprescription products, supplements, and renal function, is essential
before initiating therapy. Options A and B increase the risk of
medication errors. While some supplements may warrant
discontinuation, not all OTC products lack evidence or should be
automatically stopped (D).
Question 4
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is seeing a 58-year-old man with
newly diagnosed hypertension. The patient asks whether the
medication that "worked well" for his brother would also be the best
choice for him. Which response best reflects evidence-based
prescribing?
A. Prescribe the same medication because first-degree relatives usually
respond similarly to drug therapy.
B. Recommend delaying treatment until pharmacogenomic testing is
completed for all antihypertensive medications.
C. Select therapy after considering the patient's diagnosis,
comorbidities, current medications, kidney function, adverse-effect
risk, cost, and treatment goals.
D. Allow the patient to choose the medication based primarily on
internet reviews because adherence improves when patients select
their own therapy.
Correct Answer: C
Rationale:
Evidence-based prescribing integrates the best available evidence with
individual patient characteristics, clinician expertise, and patient
preferences. Medication selection should account for comorbidities,
concomitant medications, renal/hepatic function, adverse-effect
profiles, affordability, and therapeutic goals. Family response alone (A)
is insufficient to guide prescribing. Pharmacogenomic testing (B) has
specific indications but is not routinely required before initiating
antihypertensive therapy. Patient preferences are important, but
medication selection should not rely primarily on anecdotal reviews (D).
,Question 2
A newly licensed APRN is preparing to prescribe medications
independently. Before initiating pharmacotherapy, which action best
promotes patient safety?
A. Prescribe the newest medication available because it is likely to be
more effective.
B. Perform medication reconciliation, review allergies, assess for drug
interactions, and confirm the indication for therapy.
C. Avoid discussing potential adverse effects to prevent reducing
medication adherence.
D. Use medication samples whenever possible instead of reviewing
insurance coverage.
Correct Answer: B
Rationale:
Medication reconciliation is a fundamental patient safety practice.
Reviewing current medications, allergies, potential interactions,
contraindications, and the clinical indication helps prevent prescribing
errors and adverse drug events. Newer medications (A) are not
inherently superior and may have less post-marketing safety data.
Counseling regarding adverse effects (C) improves informed decision-
making and appropriate monitoring. Insurance coverage and cost
should be considered, but samples (D) should not replace
comprehensive prescribing evaluation.
Question 3
, A 76-year-old woman with chronic kidney disease, osteoarthritis,
hypertension, and type 2 diabetes takes eight prescription medications
and several over-the-counter supplements. Which prescribing approach
is most appropriate?
A. Add the necessary medication without reviewing the existing
regimen to avoid delaying treatment.
B. Focus only on the medication being prescribed because other
clinicians manage the remaining therapies.
C. Review all prescription medications, over-the-counter products,
herbal supplements, renal function, and potential drug interactions
before prescribing.
D. Discontinue all over-the-counter medications because they are not
evidence-based.
Correct Answer: C
Rationale:
Older adults with polypharmacy have an increased risk of adverse drug
events, drug interactions, and medication-related complications. A
comprehensive medication review, including prescription medications,
nonprescription products, supplements, and renal function, is essential
before initiating therapy. Options A and B increase the risk of
medication errors. While some supplements may warrant
discontinuation, not all OTC products lack evidence or should be
automatically stopped (D).
Question 4
